Bartlesville, OK, United States of America

Ian Mitchell

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Livepet, LLC. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Mitchell. Retrieved from https://idiyas.com/inventor/ian-mitchell-tu62ewqr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Ian Mitchell

Introduction

Ian Mitchell is an accomplished inventor based in Bartlesville, OK (US). He has made significant contributions to the field of therapeutic agents, holding a total of 3 patents. His work focuses on improving the solubility of therapeutic agents and developing innovative compounds for cancer treatment.

Latest Patents

One of Ian's latest patents involves methods and compositions to enhance the solubility of therapeutic agents. This patent describes a method that includes mixing fullerene in a lipid solution to create a lipofullerene mixture, which is then combined with the therapeutic agent. Another notable patent is centered around lipofullerene-saccharide conjugates and their application as antimetastatic agents. This invention outlines a method for inhibiting the metastasis of neoplastic cells using a lipofullerene-saccharide compound, which can be administered in therapeutically effective doses. The research has shown significant anti-metastatic effects in a metastatic nude-mouse model of human pancreatic cancer.

Career Highlights

Ian Mitchell is currently associated with Livepet, LLC, where he continues to innovate in the field of therapeutic solutions. His work has the potential to impact cancer treatment significantly, providing new avenues for research and development.

Collaborations

Ian collaborates with notable colleagues, including Ayyappan Subbiah and Daniel David Bensimon, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ian Mitchell's contributions to the field of therapeutic agents demonstrate his commitment to advancing medical science. His innovative patents and collaborative efforts position him as a key figure in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…